New doping frontier will reshape athlete’s DNA because in 2008 an Olympic year, Lee Sweeney’s phone was ringing nonstop. For an exacting physiologist at the University of Pennsylvania’s Perelman School of Medicine, that may be anticipated but their phone was ringing for an uncommon reason. The people on the other end were athletes who wanted him to dope them via genes.
In the late 1990’s Sweeney was in news because of his research on Schwarzenegger mice which had 30 percent more strength than their normal counterparts. Sweeney was able to segregate the genes accountable for triggering a protein IGF 1 that regulates muscle growth and repair.
The vital aim of his experiments was on how to set limitation to the decline of muscles with age but the consequences also allured to athletes in quest of a performance enhancement. Prior to this year’s commonwealth games which commenced on April 4th Sweeney’s was not that popular as now he is an adviser for the World Anti-Doping Agency.
Sweeney, who’s also director of the University of Florida’s Myology Institute said that at the commencement when we foremost begin publishing for this the preeminent athletes who contacted us. Now days there are mainly body builders and athletes precarious to enhance their rendition or abilities.
A few years back gene therapy, expound as the proficiency of utilizing and operating genes in face of curing or eliminating diseases. This was not so common in those years as habitual as it is today or wasn’t acknowledged as moderately a threat to be registered as a prohibited practice in sports. However, it was very soon known that gene therapies could be utilized beyond curing diseases.